BTA-9881
BTA-9881 is an orally active, novel small molecule inhibitor of respiratory syncytial virus (RSV) fusion. It is a research tool for studying RSV infections, demonstrating antiviral efficacy in both in vitro assays and in vivo animal models of respiratory disease.
Product Specifications
CAS Number
1646857-24-0
Product Name Alternative
AZD9639, AZD-9639, AZD 9639, BTA9881, BTA-9881, BTA 9881, MEDI564, MEDI-564, MEDI 564, RSV polymerase
Field of Research
Infectious Disease & Virology
Purity
99.56% (May vary between batches)
Smiles
C (=O) (N1[C@]2 (C=3C (C (=O) N2CC1) =CC=NC3) C4=CC=C (Cl) C=C4) C=5C=CC=NC5
Molecular Formula
C21H15ClN4O2
Molecular Weight
390.82
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K1225603 1.0 µg DNA
LPAR1 sgRNA CRISPR Lentivector (Human) (Target 2)
Sign In for Pricing
View Details 
GTR15099432 1 Vial
Lentiviral human ZNF585B shRNA (UAS) - Lentiviral human ZNF585B shRNA (UAS, RFP) (100)
Sign In for Pricing
View Details